Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia

Hiroyuki Yamada, Kazutoshi Iijima, Osamu Tomita, Tomoko Taguchi, Masashi Miharu, Kenichiro Kobayashi, Hajime Okita, Masahiro Saito, Toshiaki Shimizu, Nobutaka Kiyokawa

研究成果: Article査読

21 被引用数 (Scopus)


Insulin-like growth factor-1 (IGF-1) is known to be a major growth factor with effects on various cell types, including hematopoietic cells, as well as neoplasms, and is regulated by IGF-binding proteins (IGFBPs). In this study, we investigated the effects of IGF-1 on B-cell precursor acute lymphoblastic leukemia (BCP-ALL) cells. When the expression of IGF-1R in clinical samples of BCP-ALL was examined, five of thirty-two cases showed IGF-1R expression, whereas IGF-1R was expressed in most BCP-ALL cell lines. We observed that IGF-1 enhanced the proliferation of BCP-ALL cell lines that can be partially inhibited by IGFBP-1, -3, and -4, but not other IGFBPs. IGF-1 also partially inhibited dexamethasone-induced apoptosis, but not apoptosis mediated by VP-16 and irradiation. Interestingly, the proliferative effect of IGF-1 was partially blocked by inhibitors of MAPK and AKT, whereas the inhibition of dexamethasone-induced apoptosis was completely blocked by both inhibitors. Our data indicate that IGF-1 is involved in cell proliferation and apoptosis regulation in BCP-ALL cells. Since some BCP-ALL cases express IGF-1R, it appears to be a plausible target for prognostic evaluation and may represent a new therapeutic strategy.

ジャーナルInternational journal of hematology
出版ステータスPublished - 2013 1月

ASJC Scopus subject areas

  • 血液学


「Effects of insulin-like growth factor-1 on B-cell precursor acute lymphoblastic leukemia」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。